{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:27:47Z","timestamp":1794637667933,"version":"4.9.1"},"reference-count":153,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.eururo.2023.08.016","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T16:39:28Z","timestamp":1697560768000},"page":"17-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":607,"title":["European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines"],"prefix":"10.1016","volume":"85","author":[{"given":"J.","family":"Alfred Witjes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harman","family":"Max Bruins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cathomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Comp\u00e9rat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Efstathiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Gakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Lorch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew I.","family":"Milowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Neuzillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Redlef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Rouanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Thalmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e6bj\u00f8rn","family":"S\u00e6bj\u00f8rnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Veskim\u00e4e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine G.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2023.08.016_b0005","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2023.08.016_b0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.eururo.2021.09.026","article-title":"The 2021 updated European Association of Urology guidelines on metastatic urothelial carcinoma","volume":"81","author":"Cathomas","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0015","series-title":"Estimated number of new cases in 2020, worldwide, both sexes, all ages","author":"International Agency for Research on Cancer","year":"2021"},{"key":"10.1016\/j.eururo.2023.08.016_b0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/ije\/dyw044","article-title":"Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies","volume":"45","author":"van Osch","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eururo.2023.08.016_b0025","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1\u20131438."},{"key":"10.1016\/j.eururo.2023.08.016_b0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M","article-title":"Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies","volume":"86","author":"Brennan","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2023.08.016_b0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-5394.2002.106011.x","article-title":"Bladder cancer: epidemiology, diagnosis, and management","volume":"10","author":"Pashos","year":"2002","journal-title":"Cancer Pract"},{"key":"10.1016\/j.eururo.2023.08.016_b0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.ju.0000163459.57305.a1","article-title":"Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer","volume":"174","author":"Chrouser","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0050","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ijrobp.2011.08.034","article-title":"Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer","volume":"83","author":"Zelefsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2023.08.016_b0055","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1002\/ijc.31597","article-title":"Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: a prospective pooled cohort study of 800,000 men and women","volume":"143","author":"Teleka","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2023.08.016_b0060","first-page":"158","article-title":"Bilharziasis and bladder cancer: a time trend analysis of 9843 patients","volume":"19","author":"Gouda","year":"2007","journal-title":"J Egypt Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2023.08.016_b0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.urology.2011.08.072","article-title":"Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade","volume":"79","author":"Salem","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.08.016_b0070","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00345-018-2257-z","article-title":"Role of urinary tract infection in bladder cancer: a systematic review and meta-analysis","volume":"36","author":"Bayne","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00240-017-1033-7","article-title":"The risk of bladder cancer in patients with urinary calculi: a meta-analysis","volume":"46","author":"Zhang","year":"2018","journal-title":"Urolithiasis"},{"key":"10.1016\/j.eururo.2023.08.016_b0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cncr.28416","article-title":"Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation","volume":"120","author":"Cohn","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2023.08.016_b0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.euf.2019.06.001","article-title":"Sex-specific differences in the quality of treatment of muscle-invasive bladder cancer do not explain the overall survival discrepancy","volume":"7","author":"Krimphove","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2023.08.016_b0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2018.03.001","article-title":"Bladder cancer survival: women better off in the long run","volume":"95","author":"Andreassen","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2023.08.016_b0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/ije\/dyz264","article-title":"The impact of hormones and reproductive factors on the risk of bladder cancer in women: results from the Nurses\u2019 Health Study and Nurses\u2019 Health Study II","volume":"49","author":"Abufaraj","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eururo.2023.08.016_b0100","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41379-019-0403-9","article-title":"Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"33","author":"Varma","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2023.08.016_b0105","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.euo.2018.08.018","article-title":"Tumor location may predict adverse pathology and survival following definitive treatment for bladder cancer: a national cohort study","volume":"2","author":"Weiner","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0110","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.eururo.2012.09.053","article-title":"Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma","volume":"63","author":"Fritsche","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0115","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1007\/s00345-021-03630-8","article-title":"Pathological reporting of cystectomy lymph nodes: a retrospective analysis of experience in Paris","volume":"39","author":"Oszwald","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.eururo.2023.08.016_b0125","series-title":"WHO classification of tumours: urinary and male genital tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022"},{"key":"10.1016\/j.eururo.2023.08.016_b0130","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.juro.2014.09.092","article-title":"Clinical outcomes of cT1 micropapillary bladder cancer","volume":"193","author":"Willis","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0135","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3109\/00313025.2010.522173","article-title":"Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases","volume":"42","author":"Comp\u00e9rat","year":"2010","journal-title":"Pathology"},{"key":"10.1016\/j.eururo.2023.08.016_b0140","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.urolonc.2014.03.008","article-title":"Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?","volume":"32","author":"Kaimakliotis","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00428-014-1601-y","article-title":"Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder","volume":"465","author":"Beltran","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.eururo.2023.08.016_b0150","doi-asserted-by":"crossref","first-page":"21.e1","DOI":"10.1016\/j.urolonc.2014.10.013","article-title":"Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy?","volume":"33","author":"Soave","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0155","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00345-014-1387-1","article-title":"Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy","volume":"33","author":"Masson-Lecomte","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0160","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MOU.0000000000000086","article-title":"Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection","volume":"24","author":"Seisen","year":"2014","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0165","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.urolonc.2014.01.020","article-title":"Micropapillary bladder cancer: current treatment patterns and review of the literature","volume":"32","author":"Willis","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0170","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/his.14764","article-title":"What\u2019s new in WHO fifth edition \u2013 urinary tract","volume":"81","author":"Comp\u00e9rat","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2023.08.016_b0175","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumors. ed. 8. Oxford, UK: International Union Against Cancer; 2016, Oxford."},{"key":"10.1016\/j.eururo.2023.08.016_b0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.urolonc.2009.12.020","article-title":"Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy","volume":"30","author":"Ploeg","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0185","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/cancers13061396","article-title":"Imaging and management of bladder cancer","volume":"13","author":"Wong","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.eururo.2023.08.016_b0190","doi-asserted-by":"crossref","first-page":"532.e1","DOI":"10.1016\/j.urolonc.2016.06.014","article-title":"Accuracy of urethral frozen section during radical cystectomy for bladder cancer","volume":"34","author":"Kates","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0195","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.juro.2018.04.065","article-title":"Can renal and bladder ultrasound replace computerized tomography urogram in patients investigated for microscopic hematuria?","volume":"200","author":"Tan","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2020.07.021","article-title":"Diagnostic accuracy of multiparametric MRI for local staging of bladder cancer: a systematic review and meta-analysis","volume":"145","author":"Cornelissen","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.08.016_b0205","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0210","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s11547-022-01513-5","article-title":"A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study","volume":"127","author":"Bicchetti","year":"2022","journal-title":"Radiol Med"},{"key":"10.1016\/j.eururo.2023.08.016_b0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.euo.2022.07.006","article-title":"Diagnostic value of the Vesical Imaging-Reporting and Data System in bladder urothelial carcinoma with variant histology","volume":"6","author":"Arita","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2021.02.021","article-title":"Comparing an imaging-guided pathway with the standard pathway for staging muscle-invasive bladder cancer: preliminary data from the BladderPath study","volume":"80","author":"Bryan","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0225","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00261-021-03383-3","article-title":"Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion?","volume":"47","author":"Aslan","year":"2022","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.eururo.2023.08.016_b0230","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2214\/ajr.180.4.1801045","article-title":"Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder","volume":"180","author":"Kundra","year":"2003","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.eururo.2023.08.016_b0235","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.juro.2010.12.035","article-title":"Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma","volume":"185","author":"Ito","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0240","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1464-410X.2007.06766.x","article-title":"Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour","volume":"99","author":"Cowan","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.08.016_b0245","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.juro.2009.12.031","article-title":"Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy","volume":"183","author":"Takahashi","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0250","doi-asserted-by":"crossref","first-page":"195.e27","DOI":"10.1016\/j.urolonc.2022.01.002","article-title":"Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: a multicenter cohort from the European Association of Urology - Young Academic Urologists","volume":"40","author":"Lonati","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0255","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.eururo.2022.09.017","article-title":"Positron emission tomography\/computed tomography for staging of bladder cancer: a continuing clinical controversy","volume":"83","author":"Mertens","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0260","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.euo.2021.01.005","article-title":"Staging 18F-fluorodeoxyglucose positron emission tomography\/computed tomography changes treatment recommendation in invasive bladder cancer","volume":"5","author":"Voskuilen","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0265","doi-asserted-by":"crossref","first-page":"235.e15","DOI":"10.1016\/j.urolonc.2020.09.035","article-title":"[18F]Fluoro-deoxy-glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab","volume":"39","author":"Marandino","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0270","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.euf.2020.09.016","article-title":"Routine preoperative bone scintigraphy has limited impact on the management of patients with invasive bladder cancer","volume":"7","author":"Furrer","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2023.08.016_b0275","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s12094-019-02257-x","article-title":"Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer","volume":"22","author":"Papageorgiou","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0280","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.euo.2020.06.004","article-title":"The value of multiparametric magnetic resonance imaging sequences to assist in the decision making of muscle-invasive bladder cancer","volume":"4","author":"Bandini","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0285","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clon.2022.04.001","article-title":"Assessing bladder radiotherapy response with quantitative diffusion-weighted magnetic resonance imaging analysis","volume":"34","author":"Hafeez","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0290","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00261-021-03365-5","article-title":"Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report","volume":"47","author":"Pecoraro","year":"2022","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.eururo.2023.08.016_b0295","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.euf.2021.05.005","article-title":"Role of radiomics in the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"8","author":"Kozikowski","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2023.08.016_b0300","doi-asserted-by":"crossref","first-page":"787.e17","DOI":"10.1016\/j.urolonc.2021.04.024","article-title":"Clinical value of 18FDG PET\/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer","volume":"39","author":"Civelek","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0305","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/RLU.0000000000004301","article-title":"Evaluation of the hybrid tracer indocyanine green-99mTc-nanocolloid for sentinel node biopsy in bladder cancer-a prospective pilot study","volume":"47","author":"Rietbergen","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.eururo.2023.08.016_b0310","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3322\/caac.21406","article-title":"Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology","volume":"67","author":"Ethun","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2023.08.016_b0315","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.euf.2017.08.005","article-title":"Comparative perioperative outcomes in septuagenarians and octogenarians undergoing radical cystectomy for bladder cancer\u2014do outcomes differ?","volume":"4","author":"Haden","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2023.08.016_b0320","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clgc.2019.03.007","article-title":"Sarcopenia and response to neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"17","author":"Lyon","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2023.08.016_b0325","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jgo.2014.10.002","article-title":"Prevention of post-operative delirium in older patients with cancer undergoing surgery","volume":"6","author":"Korc-Grodzicki","year":"2015","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0330","doi-asserted-by":"crossref","first-page":"531.e1","DOI":"10.1016\/j.urolonc.2016.06.009","article-title":"Effect of tumor location on survival in urinary bladder adenocarcinoma: a population-based analysis","volume":"34","author":"Dutta","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0335","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrurol.2016.126","article-title":"The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder","volume":"13","author":"Mathieu","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0340","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.juro.2018.05.162","article-title":"Prognostic value of concomitant carcinoma in situ in the radical cystectomy specimen: a systematic review and meta-analysis","volume":"201","author":"Kimura","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0345","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.urology.2014.05.011","article-title":"Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy","volume":"84","author":"Svatek","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.08.016_b0350","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/BLC-160086","article-title":"Impact of the level of urothelial carcinoma involvement of the prostate on survival after radical cystectomy","volume":"3","author":"Moschini","year":"2017","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.eururo.2023.08.016_b0355","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s12885-015-1448-x","article-title":"Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis","volume":"15","author":"Ku","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2023.08.016_b0360","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0365","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/JU.0000000000000351","article-title":"Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: results from multiple cohorts, including TCGA","volume":"203","author":"Morera","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0370","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2018.09.002","article-title":"Genomic differences between \u201cprimary\u201d and \u201csecondary\u201d muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy","volume":"75","author":"Pietzak","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0375","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-021-03642-9","article-title":"ctDNA guiding adjuvant immunotherapy in urothelial carcinoma","volume":"595","author":"Powles","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2023.08.016_b0380","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.eururo.2023.08.016_b0385","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1817323","article-title":"Erdafitinib in locally advanced or metastatic urothelial carcinoma","volume":"381","author":"Loriot","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2023.08.016_b0390","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.euo.2018.09.004","article-title":"Delaying radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer is associated with adverse survival outcomes","volume":"2","author":"Boeri","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0395","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.eururo.2003.09.019","article-title":"Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies","volume":"45","author":"Sherif","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0400","doi-asserted-by":"crossref","unstructured":"Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data. Eur Urol 2005;48:202\u20135.","DOI":"10.1016\/j.eururo.2005.04.006"},{"key":"10.1016\/j.eururo.2023.08.016_b0405","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","article-title":"Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis","volume":"21","author":"Yin","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.eururo.2023.08.016_b0410","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2020.08.024","volume":"79","author":"Pfister","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0415","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jamaoncol.2018.3542","article-title":"Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer","volume":"4","author":"Peyton","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0420","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1002\/cncr.30907","article-title":"Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology","volume":"123","author":"Vetterlein","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2023.08.016_b0425","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1097\/PAS.0000000000001371","article-title":"Multicenter validation of histopathologic tumor regression grade after neoadjuvant chemotherapy in muscle-invasive bladder carcinoma","volume":"43","author":"Voskuilen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2023.08.016_b0430","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.eururo.2022.04.013","article-title":"Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder","volume":"82","author":"Szabados","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0435","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.urolonc.2019.05.021","article-title":"The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: a systematic review","volume":"37","author":"Iwata","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0440","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.euo.2019.09.008","article-title":"A systematic review and meta-analysis of delay in radical cystectomy and the effect on survival in bladder cancer patients","volume":"3","author":"Russell","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0445","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.juro.2016.08.088","article-title":"Clinicopathological features and prognostic value of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens: a systematic review and meta-analysis of 13,140 patients","volume":"197","author":"Fahmy","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0450","series-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG prostate cancer guidelines","author":"Mottet","year":"2023"},{"key":"10.1016\/j.eururo.2023.08.016_b0455","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.sxmr.2019.03.005","article-title":"Influence of simple and radical cystectomy on sexual function and pelvic organ prolapse in female patients: a scoping review of the literature","volume":"7","author":"Voigt","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.eururo.2023.08.016_b0460","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/GRF.0000000000000318","article-title":"Ovarian cancer prevention in high-risk women","volume":"60","author":"Temkin","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.eururo.2023.08.016_b0465","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/bju.13819","article-title":"Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer","volume":"120","author":"Veskimae","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.08.016_b0470","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clgc.2021.11.005","article-title":"Safety and efficacy of reproductive organ-sparing radical cystectomy in women with variant histology and advanced stage","volume":"20","author":"Patel","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2023.08.016_b0475","doi-asserted-by":"crossref","first-page":"354.e1","DOI":"10.1016\/j.urolonc.2019.01.028","article-title":"Robotic vs. open cystectomy: how length-of-stay differences relate conditionally to age","volume":"37","author":"Faraj","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0480","first-page":"CD011903","article-title":"Robotic versus open radical cystectomy for bladder cancer in adults","volume":"2019","author":"Rai","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2023.08.016_b0485","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.urolonc.2019.07.019","article-title":"Robot assisted radical cystectomy vs open radical cystectomy: over 10 years of the Mayo Clinic experience","volume":"37","author":"Faraj","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0490","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1001\/jama.2022.7393","article-title":"Effect of robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy on 90-day morbidity and mortality among patients with bladder cancer: a randomized clinical trial","volume":"327","author":"Catto","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2023.08.016_b0495","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.eururo.2020.12.023","article-title":"Robot-assisted radical cystectomy versus open radical cystectomy in bladder cancer patients: a multicentre comparative effectiveness study","volume":"79","author":"Wijburg","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0500","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/bju.14733","article-title":"Use of indocyanine green to minimise uretero-enteric strictures after robotic radical cystectomy","volume":"124","author":"Ahmadi","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.08.016_b0505","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/JU.0000000000001518","article-title":"Evaluation of ureteroenteric anastomotic strictures after the introduction of robot-assisted radical cystectomy with intracorporeal urinary diversion: results from a large tertiary referral center","volume":"205","author":"Reesink","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0510","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.juro.2017.12.045","article-title":"Outcomes of intracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium","volume":"199","author":"Hussein","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0515","doi-asserted-by":"crossref","first-page":"368.e11","DOI":"10.1016\/j.urolonc.2020.11.042","article-title":"Outcomes of palliative cystectomy in patients with locally advanced pT4 bladder cancer","volume":"39","author":"Maisch","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0520","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/JU.0000000000001696","article-title":"Complications and outcomes of salvage cystectomy after trimodality therapy","volume":"206","author":"Pieretti","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0525","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.eururo.2011.07.012","article-title":"Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study","volume":"60","author":"Dorin","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0530","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.eururo.2018.09.047","article-title":"Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial","volume":"75","author":"Gschwend","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0535","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000487644","article-title":"Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with ileal orthotopic neobladder or ileal conduit: results from a multicentre cross-sectional study using validated questionnaires","volume":"100","author":"Cerruto","year":"2018","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2023.08.016_b0540","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/s1677-5538.ibju.2020.0892","article-title":"Bricker ileal conduit vs. cutaneous ureterostomy after radical cystectomy for bladder cancer: a systematic review","volume":"48","author":"Korkes","year":"2022","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0545","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.urology.2005.03.031","article-title":"Urinary diversion in high-risk elderly patients: modified cutaneous ureterostomy or ileal conduit?","volume":"66","author":"Deliveliotis","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.08.016_b0550","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.urology.2022.08.020","article-title":"Ileal conduit versus continent urinary diversion in radical cystectomy: a retrospective cohort study of 30-day complications, readmissions, and mortality","volume":"170","author":"Rezaee","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.08.016_b0555","first-page":"225","article-title":"Radical cystectomy and orthotopic bladder substitution: surgical tricks and management of complications","volume":"65","author":"Izquierdo","year":"2013","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.eururo.2023.08.016_b0560","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.urolonc.2021.06.009","article-title":"Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: a systematic review and meta-analysis","volume":"39","author":"Laukhtina","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0565","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/JU.0000000000000512","article-title":"Decision regret related to urinary diversion choice among patients treated with cystectomy","volume":"203","author":"Check","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0570","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/JU.0000000000000034","article-title":"Positive pre-cystectomy biopsies of the prostatic urethra or bladder neck do not necessarily preclude orthotopic bladder substitution","volume":"201","author":"Roth","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0575","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0031-1271413","article-title":"Benefits and risks of orthotopic neobladder reconstruction in female patients","volume":"42","author":"Gakis","year":"2011","journal-title":"Aktuelle Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0580","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.862884","article-title":"Comparison of health-related quality of life between ileal conduit diversion and orthotopic neobladder in women: a meta-analysis","volume":"12","author":"Xing","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0585","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.eururo.2020.06.039","article-title":"Reporting radical cystectomy outcomes following implementation of enhanced recovery after surgery protocols: a systematic review and individual patient data meta-analysis","volume":"78","author":"Williams","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0590","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.juro.2015.05.083","article-title":"Postoperative pain management after radical cystectomy: comparing traditional versus enhanced recovery protocol pathway","volume":"194","author":"Xu","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0595","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/bju.14636","article-title":"Examining the relationship between complications and perioperative mortality following radical cystectomy: a population-based analysis","volume":"124","author":"Mossanen","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.08.016_b0600","doi-asserted-by":"crossref","first-page":"408","DOI":"10.23736\/S0393-2249.20.03641-3","article-title":"Complications and quality of life of ileal conduit, orthotopic neobladder and ureterocutaneostomy: systematic review of reports using the Clavien-Dindo classification","volume":"72","author":"Cicione","year":"2020","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.eururo.2023.08.016_b0605","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.euo.2019.11.005","volume":"3","author":"Bruins","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0610","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/bju.15334","article-title":"Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer","volume":"128","author":"Richters","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.08.016_b0615","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.juro.2010.04.008","article-title":"Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer","volume":"184","author":"Solsona","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0620","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1470-2045(20)30607-0","article-title":"Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials","volume":"22","author":"Choudhury","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0625","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","article-title":"Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer","volume":"366","author":"James","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2023.08.016_b0630","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.eururo.2019.09.035","article-title":"EAU-ESMO consensus statements on the management of advanced and variant bladder cancer\u2014an international collaborative multistakeholder effort","volume":"77","author":"Witjes","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0635","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1200\/JCO.2016.69.2327","article-title":"Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic","volume":"35","author":"Kulkarni","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0640","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.urolonc.2017.10.002","article-title":"A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"36","author":"Fahmy","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0645","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eururo.2019.11.001","article-title":"Patient-reported quality of life outcomes in patients treated for muscle-invasive bladder cancer with radiotherapy \u00b1 chemotherapy in the BC2001 phase III randomised controlled trial","volume":"77","author":"Huddart","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0650","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ijrobp.2016.08.023","article-title":"Quality of life in long-term survivors of muscle-invasive bladder cancer","volume":"96","author":"Mak","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2023.08.016_b0655","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s13566-019-00411-0","article-title":"Intensity-modulated radiotherapy is superior to three-dimensional conformal radiotherapy in the trimodality management of muscle-invasive bladder cancer with daily cone beam computed tomography optimization","volume":"8","author":"Sherry","year":"2019","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0660","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eururo.2021.09.028","article-title":"Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and meta-analysis of individual participant data from randomised controlled trials","volume":"81","author":"Advanced Bladder Cancer (ABC) Meta-analysis Collaborators Group","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0665","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/cncr.31952","article-title":"Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: does histologic subtype matter?","volume":"125","author":"Berg","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2023.08.016_b0670","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2023.08.016_b0675","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(21)00004-8","article-title":"Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Bellmunt","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0680","unstructured":"US Food & Drug Administration. FDA approves nivolumab for adjuvant treatment of urothelial carcinoma. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-nivolumab-adjuvant-treatment-urothelial-carcinoma."},{"key":"10.1016\/j.eururo.2023.08.016_b0685","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.suronc.2016.05.027","article-title":"A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer","volume":"25","author":"Yang","year":"2016","journal-title":"Surg Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0690","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2008.11.112","article-title":"Oncological followup after radical cystectomy for bladder cancer \u2013 is there any benefit?","volume":"181","author":"Volkmer","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0695","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.juro.2011.07.005","article-title":"Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival","volume":"186","author":"Boorjian","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0700","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2012.05.008","article-title":"Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature","volume":"62","author":"Soukup","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0705","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.5489\/cuaj.1205","article-title":"Surveillance strategies after definitive therapy of invasive bladder cancer","volume":"3","author":"Cagiannos","year":"2009","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.eururo.2023.08.016_b0710","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s10147-011-0350-z","article-title":"Could salvage surgery after chemotherapy have clinical impact on cancer survival of patients with metastatic urothelial carcinoma?","volume":"18","author":"Bekku","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0715","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.urolonc.2017.11.007","article-title":"Urethral recurrence after radical cystectomy for urothelial carcinoma: a systematic review and meta-analysis","volume":"36","author":"Fahmy","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.08.016_b0720","series-title":"EAU guidelines on primary urethral carcinoma","author":"Gakis","year":"2023"},{"key":"10.1016\/j.eururo.2023.08.016_b0725","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.juro.2012.08.017","article-title":"Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients","volume":"188","author":"Picozzi","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0730","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/JU.0000000000001886","article-title":"Oncologic surveillance for variant histology bladder cancer after radical cystectomy","volume":"206","author":"Martini","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0735","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.urology.2015.03.014","article-title":"Ureteroenteric strictures after open radical cystectomy and urinary diversion: the University of Southern California experience","volume":"86","author":"Shah","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.08.016_b0740","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.euros.2021.11.001","article-title":"Renal morbidity following radical cystectomy in patients with bladder cancer","volume":"35","author":"Schmidt","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.eururo.2023.08.016_b0745","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.juro.2016.05.093","article-title":"Prospective evaluation of continence following radical cystectomy and orthotopic urinary diversion using a validated questionnaire","volume":"196","author":"Clifford","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0750","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00345-013-1219-8","article-title":"Urinary functional outcomes in female neobladder patients","volume":"32","author":"Bartsch","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0755","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/JU.0000000000001345","article-title":"Functional outcome and complications following ileal neobladder reconstruction in male patients without tumor recurrence: more than 35 years of experience from a single center","volume":"205","author":"Hautmann","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.08.016_b0760","unstructured":"Witjes JA, Bruins HM, Carri\u00f3n A, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer. Arnhem, The Netherlands: European Association of Urology; 2023. https:\/\/uroweb.org\/guidelines\/muscle-invasive-and-metastatic-bladder-cancer."},{"key":"10.1016\/j.eururo.2023.08.016_b0765","series-title":"EAU guidelines on upper urinary tract urothelial carcinoma","author":"Roupr\u00eat","year":"2023"}],"updated-by":[{"DOI":"10.1016\/j.eururo.2024.03.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823030737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823030737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T23:22:31Z","timestamp":1702682551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283823030737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0302283823030737"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2023.08.016","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2023.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}